Literature DB >> 15567583

Epidemiology of microsporidiosis: sources and modes of transmission.

E S Didier1, M E Stovall, L C Green, P J Brindley, K Sestak, P J Didier.   

Abstract

Microsporidia are single-celled, obligate intracellular parasites that were recently reclassified from protozoa to fungi. Microsporidia are considered a cause of emerging and opportunistic infections in humans, and species infecting humans also infect a wide range of animals, raising the concern for zoonotic transmission. Persistent or self-limiting diarrhea are the most common symptoms associated with microsporidiosis in immune-deficient or immune-competent individuals, respectively. Microsporidian spores appear to be relatively resistant under environmental conditions, and species of microsporidia infecting humans and animals have been identified in water sources, raising concern about water-borne transmission. Sensitive and specific immunomagnetic bead separation and PCR-based methods are being developed and applied for detecting microsporidia in infected hosts and water sources for generating more reliable prevalence data. The most effective drugs for treating microsporidiosis in humans currently include albendazole, which is effective against the Encephalitozoon species but not against Enterocytozoon bieneusi, and fumagillin, which has broader anti-microsporidia activity but is toxic in mammals, suggesting a need to identify better drugs. Strategies to capture and disinfect microsporidia in water are being developed and include filtration, coagulation, chlorination, gamma-irradiation, and ozonation.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15567583     DOI: 10.1016/j.vetpar.2004.09.006

Source DB:  PubMed          Journal:  Vet Parasitol        ISSN: 0304-4017            Impact factor:   2.738


  77 in total

1.  Prevalence of microsporidium and other intestinal parasites in children from malatya, Turkey.

Authors:  Sinan Calik; Ulku Karaman; Cemil Colak
Journal:  Indian J Microbiol       Date:  2011-01-26       Impact factor: 2.461

Review 2.  Microsporidiosis: current status.

Authors:  Elizabeth S Didier; Louis M Weiss
Journal:  Curr Opin Infect Dis       Date:  2006-10       Impact factor: 4.915

3.  Chronic microsporidial enteritis in a missionary from Mozambique.

Authors:  James R Palmieri; Shaadi F Elswaifi; David S Lindsay; Gretchen Junko; Cathy Callahan
Journal:  Am J Trop Med Hyg       Date:  2010-11       Impact factor: 2.345

4.  Induction of host chemotactic response by Encephalitozoon spp.

Authors:  Jeffrey Fischer; Jeffrey West; Nnenaya Agochukwu; Colby Suire; Hollie Hale-Donze
Journal:  Infect Immun       Date:  2006-12-18       Impact factor: 3.441

Review 5.  Parasitic central nervous system infections in immunocompromised hosts: malaria, microsporidiosis, leishmaniasis, and African trypanosomiasis.

Authors:  Melanie Walker; James G Kublin; Joseph R Zunt
Journal:  Clin Infect Dis       Date:  2005-11-23       Impact factor: 9.079

6.  Antimicrosporidial activities of fumagillin, TNP-470, ovalicin, and ovalicin derivatives in vitro and in vivo.

Authors:  Peter J Didier; Jennifer N Phillips; Dorothy J Kuebler; Mohamed Nasr; Paul J Brindley; Mary E Stovall; Lisa C Bowers; E S Didier
Journal:  Antimicrob Agents Chemother       Date:  2006-06       Impact factor: 5.191

7.  Quantitative assessment of contamination of fresh food produce of various retail types by human-virulent microsporidian spores.

Authors:  Szymon Jedrzejewski; Thaddeus K Graczyk; Anna Slodkowicz-Kowalska; Leena Tamang; Anna C Majewska
Journal:  Appl Environ Microbiol       Date:  2007-04-20       Impact factor: 4.792

8.  Isolation of Encephalitozoon intestinalis from crows living in urban parks of Tehran, Iran: an investigation with zoonotic aspect.

Authors:  Majid Yazdanjooie; Javid Sadraei; Abdolhosein Dalimi; Majid Pirestani
Journal:  J Parasit Dis       Date:  2018-08-22

Review 9.  Parasitic infections and myositis.

Authors:  Samar N El-Beshbishi; Nairmen N Ahmed; Samar H Mostafa; Goman A El-Ganainy
Journal:  Parasitol Res       Date:  2011-09-01       Impact factor: 2.289

10.  Effect of three drugs against Encephalitozoon cuniculi infection in immunosuppressed mice.

Authors:  Maria Anete Lallo; Lidiana F Vidoto da Costa; João Manoel de Castro
Journal:  Antimicrob Agents Chemother       Date:  2013-04-22       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.